{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-130803","form_type":"8-K/A","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.228790+00:00","generated_at":"2026-05-29T00:11:16.426735+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Cara Therapeutics files amended 8-K to correct investor presentation for proposed merger with Tvardi Therapeutics","bullets":["Merger agreement with Tvardi Therapeutics and merger sub was signed on December 17, 2024.","Asset Purchase Agreement with Vifor Fresenius Medical Care Renal Pharma for disposition of assets was signed on December 17, 2024.","Stockholder support agreements and lock-up agreements were filed with the SEC on December 17, 2024.","This amendment corrects formatting errors in the investor presentation originally filed on December 18, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-130803","json":"https://secwatch.observer/filing/0001104659-24-130803.json","markdown":"https://secwatch.observer/filing/0001104659-24-130803.md","text":"https://secwatch.observer/filing/0001104659-24-130803.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/0001104659-24-130803-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/tm2431662d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-29T00:11:16.426735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}